Stay updated on Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial
Sign up to get notified when there's something new on the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page.

Latest updates to the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page
- Check6 days agoChange DetectedLocations section was reorganized: a new general Locations header appears and state site entries (California, Colorado, Illinois, Michigan, North Carolina) were added or removed, with the revision version updated from v3.3.2 to v3.3.3.SummaryDifference0.7%

- Check13 days agoChange DetectedThe changes appear to be cosmetic UI adjustments with no substantive updates to study details, outcomes, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe screenshots show no substantive changes to the Study Details page; the study title, conditions, interventions, locations, and outcome measures appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no user-facing content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1, with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRemoved the page-wide notice about government funding and potential delays in updates (including references to cc.nih.gov and opm.gov). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page.